Skip to content
Abierto
Menu

Award notice

Development Of a Concentrated Tranexamic Acid (TXA) Intramuscular Injection

75A50125C00018

Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).

View on SAM.govMarkdown

Awarded

Rafa Laboratories Ltd.

$186,004,780.00 on the award notice, September 30, 2025, contract 75A50125C00018

Description

As published on SAM.gov.

This award is for the development of a concentrated Tranexamic Acid (TXA) Intramuscular Injection. The Government seeks this development in order to receive FDA approval for the concentrated IM TXA formulation that can be delivered in a pref-filled syringe or a dedicated autoinjector. This contract action was awarded competitively as a Cost Share Contract. A Cost Share Contract was used in accordance with FAR 35.006 (c) due to an absence of precise specifications and difficulties in estimating costs with accuracy.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Rafa Laboratories Ltd.
UEI
CKDNTKNDPMJ6
CAGE
0905A
Vendor location
Jerusalem
Contract
75A50125C00018, definitive contract
Obligated
$11,997,762.00, potential $147,733,954
Actions
2 between September 30, 2025 and August 10, 2026
Competition
Full and Open Competition, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
The Scope of Work for This Contract Includes the Following Development Essentials: CMC Development, Pre-Clinical and Clinical Studies, Device Development Activities, Human Factors Testing, Market Viability Assessments Along with All Associated Regula
Match
award number 75A50125C00018 equals the contract number; same awarding office 75A501 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 1, 2025

    Award notice, originally solicitation

    Awarded to RAFA LABORATORIES Ltd. Jerusalem ISR for $186,004,780. SAM.gov, notice 4019083ffaab4e8da012f8752b7ebcee

Points of contact

Also open from this buyer